Company: HCTI
Filing Date: 2025-11-19
Form Type: S-3/A
Source: 0001213900-25-112651
Chunk: 20

Company: Healthcare Triangle, Inc.
Filing Date: 2025-11-19
Form: S-3/A
Chunk 20
---
 prospectus for a discussion of factors you should carefully consider before investing in our securities.                         |
| Nasdaq Capital Market trading symbol                  |     | Our Common Stock is listed on the Nasdaq Capital                                                                                         
 Market under the symbol “HCTI.”                                                                                                          |

| (1) | The number of shares of Common Stock to be outstanding immediately                                                                   
 after this offering is based on 5,873,303 shares of Common Stock outstanding as of November 18, 2025, and excludes, as of such date: |

| ● | 1,485,908 shares of Common Stock issuable upon the exercise of                            
 outstanding warrants with a weighted average exercise price equal to $8.48 per share; and |

<div align='center'>10

RISK FACTORS</div>

Investing in our securities involves a high degree of risk. You should carefully consider the risks described in the documents incorporated by reference in this prospectus and any prospectus supplement, as well as other information we include or incorporate by reference into this prospectus and any applicable prospectus supplement, before making an investment decision. Our business, financial condition or results of operations could be materially adversely affected by the materialization of any of these risks. The trading price of our securities could decline due to the materialization of any of these risks, and you may lose all or part of your investment. This prospectus and the documents incorporated herein by reference also contain forward-looking statements that involve risks and uncertainties. Actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including the risks described in the documents incorporated herein by reference, together with the other information set forth in this prospectus, the risks described in Part I, Item 1A, Risk Factors in our most recent Annual Report on Form 10-K and in the other documents that we include or incorporate by reference into this prospectus, as updated by our Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and other filings we make with the SEC, the risk factors described under the caption “Risk Factors” in any applicable prospectus supplement and any risk factors set forth in our other filings with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, before making a decision about investing in our securities. The risks and uncertainties we have described are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our operations